Delivery Order SPE2DB22D2007-SPE2DB25FH7MZ

Award Date 12/6/24
Potential Completion Date 12/9/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH7MZ
    Delivery Order

This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The contract, valued at $1,553.03, was awarded by the Defense Logistics Agency (DLA) on December 6, 2024, with a completion date of December 9, 2024. It is a firm fixed-price delivery order contract with no set-aside designation.

Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 3/7/25, 9:42 AM